There are 2 vaccines available for use within Australia to prevent the development of herpes zoster (shingles).

Zostavax is a live-attenuated vaccine and is funded on the National Immunisation Program (NIP) for immunocompetent adults aged 70 years and over.

Shingrix is a non-live vaccine. It is the preferred vaccine for those aged over 50 years due to a higher efficacy. It is currently only available for private purchase and availability is limited.

ATAGI have released a statement informing the use both vaccines. To read the statement in full please follow the link below:

ATAGI: Statement on the clinical use of zoster vaccines in older adults in Australia